M&A - Addus HomeCare Corp

Add to your watchlist
Back to List of Mergers and Acquisitions

Form Type: 10-K

Filing Date: 2025-02-25

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025026747

Filing Summary: Addus HomeCare Corporation provides an annual report under Form 10-K for the fiscal year ending December 31, 2024. The document outlines the company's business operations, financial results, and strategic objectives. It highlights the acquisition of Gentiva Health Services, which enhances Addus's service offerings in home health and hospice care. The report details risks associated with the industry, revenue generated from different segments, and operational performance metrics. It also discusses regulatory issues, competitive landscape, and financial commitments through credit agreements. The filing indicates the company's substantial growth within the home care sector and underlines its expanding geographic presence across the United States.

Additional details:

Title: company_name

Value: Addus HomeCare Corporation


Title: fiscal_year_end

Value: 2024-12-31


Title: acquisition_details

Value: Acquisition of Gentiva Health Services


Title: credit_agreement

Value: CapitalOne Credit Agreement


Title: operational_segments

Value: Home Health, Hospice, Personal Care


Title: market_value

Value: 2061491000


Title: common_stock_par_value

Value: 0.001


Title: trading_symbol

Value: ADUS


Form Type: 8-K/A

Filing Date: 2025-02-14

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025021397

Filing Summary: This amendment updates the original Form 8-K filed on December 2, 2024, by Addus HomeCare Corporation, reporting on the acquisition of the personal care business of Curo Health Services, LLC, conducted by its wholly-owned subsidiary, Addus HealthCare, Inc. Key updates include the inclusion of audited and unaudited financial statements of the acquired business, KAH Hospice Company-Personal Care, as of December 31, 2023, and the nine-month period ended September 30, 2024, along with pro forma combined financial statements. The filing ensures that all financial documentation relevant to the acquisition is now presented alongside the initial disclosures.

Additional details:

Item 9 01 Financial Statements Of Business Acquired: Includes audited financial statements as of December 31, 2023, and unaudited financial statements for the nine months ended September 30, 2024.


Exhibits Description: Includes consent from PricewaterhouseCoopers regarding audited financials, and details of the financial statements.


Comments

No comments yet. Be the first to comment!